CARE Ratings to Participate in YES Securities' India Manthan 2026 Institutional Equities Conference on 21 May 2026

1 min read     Updated on 19 May 2026, 10:49 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

CARE Ratings Limited has intimated stock exchanges of its participation in YES Securities' 1st Flagship Institutional Equities Conference – India Manthan 2026: Rising Soft Power, scheduled for 21 May 2026 in Mumbai. The disclosure was made under Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has confirmed that only publicly available information will be referenced, with no unpublished price sensitive information (UPSI) to be discussed. The Investor Presentation for Q4 and FY26 has been made available on the company's website.

powered bylight_fuzz_icon
40713533

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has notified the stock exchanges of its planned participation in an upcoming institutional investor conference, in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated 15 May 2026, was submitted pursuant to Regulation 30(6) of the said regulations.

Conference Participation Details

The company's officials are scheduled to attend YES Securities' 1st Flagship Institutional Equities Conference – India Manthan 2026: Rising Soft Power. The key details of the event are as follows:

Parameter: Details
Date: 21 May 2026
Time: 09:00 AM Onwards
Organised By: YES Securities' 1st Flagship Institutional Equities Conference – India Manthan 2026: Rising Soft Power
Location: Mumbai

Disclosure and Compliance

CARE Ratings has stated that its representatives will refer only to publicly available documents during the discussions at the conference. The company has explicitly clarified that no unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. The company has also noted that changes to the schedule may occur due to exigencies on the part of participants or the company.

Investor Presentation

In connection with the conference, the company has made its Investor Presentation for Q4 and FY26 available on its official website. Investors and stakeholders may access the presentation through the company's website at www.careedge.in for reference ahead of the event.

The intimation was signed by Manoj Kumar CV, Company Secretary & Compliance Officer of CARE Ratings Limited, on 15 May 2026.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+1.69%+0.46%+1.56%+6.28%-16.15%+170.21%

What key financial metrics or strategic growth initiatives from CARE Ratings' Q4 and FY26 results are likely to attract the most attention from institutional investors at the conference?

How might CARE Ratings' participation in high-profile institutional conferences impact its visibility and valuation multiples relative to competing credit rating agencies like ICRA and CRISIL?

Given India's expanding credit market and the 'Rising Soft Power' theme of the conference, how could regulatory changes or RBI policy shifts affect CARE Ratings' business pipeline in FY27?

CARE Ratings Allots 300 Equity Shares Under ESOP, Grants 18,000 Fresh Stock Options

1 min read     Updated on 05 May 2026, 09:24 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

CARE Ratings' NRC approved the allotment of 300 equity shares under CARE Employee Stock Option Scheme 2020 on May 04, 2026, increasing paid-up share capital from Rs. 30,04,88,630 to Rs. 30,04,91,630. The NRC also granted 18,000 fresh stock options at an exercise price of Rs. 1,590/-, vesting in equal one-third tranches over three years, with a two-year exercise window post-vesting.

powered bylight_fuzz_icon
39484528

*this image is generated using AI for illustrative purposes only.

The Nomination and Remuneration Committee (NRC) of CARE Ratings Limited approved the allotment of 300 equity shares of face value Rs. 10/- each, fully paid up, to employees of the company pursuant to the exercise of their options under CARE Employee Stock Option Scheme 2020. The meeting of the NRC was held on May 04, 2026, commencing at 2:30 PM and concluding at 5:30 PM.

Impact on Paid-Up Share Capital

The allotment of 300 equity shares has resulted in an increase in the company's paid-up share capital. The following table summarises the change:

Metric: Before Allotment After Allotment
Paid-up Share Capital: Rs. 30,04,88,630/- Rs. 30,04,91,630/-
Number of Equity Shares: 3,00,48,863 3,00,49,163
Face Value per Share: Rs. 10/- Rs. 10/-

Grant of Fresh Stock Options

In addition to the share allotment, the NRC also approved the grant of 18,000 stock options to eligible employees under the CARE Employee Stock Option Scheme 2020. The scheme is in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The key terms and conditions of the options granted are detailed below:

Parameter: Details
No. of Stock Options Granted: 18,000 (Eighteen Thousand)
Equity Shares Covered: 18,000 equity shares of face value Rs. 10/- each
Exercise Price: Rs. 1,590/-
SEBI Regulation Compliance: Yes — SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
Exercise Period: 2 years from the date of vesting of options

Vesting Schedule

The 18,000 stock options will vest in equal tranches over a period of three years from the date of grant, as outlined below:

  • 1/3rd of options vest on completion of one year from the date of grant
  • 1/3rd of options vest on completion of the second year from the date of grant
  • 1/3rd of options vest on completion of the third year from the date of grant

The information pertaining to the allotment and the grant of stock options has been made available on the company's website at www.careedge.in . The disclosure was made by Manoj Kumar CV, Company Secretary & Compliance Officer of CARE Ratings Limited.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+1.69%+0.46%+1.56%+6.28%-16.15%+170.21%

How might the exercise price of Rs. 1,590/- for the newly granted options compare to CARE Ratings' stock performance over the three-year vesting period, and what does this signal about management's confidence in future growth?

Could the gradual dilution from ESOP exercises under the 2020 scheme impact CARE Ratings' earnings per share trajectory, and how are institutional investors likely to respond to continued share capital expansion?

As CARE Ratings continues to grant fresh stock options, what retention challenges or talent competition pressures in the credit rating industry might be driving the need for equity-based compensation?

More News on CARE Ratings

1 Year Returns:-16.15%